Sign up Australia
Proactive Investors - Run By Investors For Investors

Zelda Therapeutics' soaring shares attract ASX speeding ticket

The halt will remain in place until Thursday 23rd November 2017.
Zelda Therapeutics' soaring shares attract ASX speeding ticket
The company's shares are in pre-open

Zelda Therapeutics Ltd's (ASX:ZLD) shares are currently in pre-open following the ASX granting the company a trading halt.

Zelda requested the halt pending a response to an ASX price query.

The stock had jumped 24% intra-day to $0.11 before the halt was called.

WATCH NOW: Zelda Therapeutics' Dr Stewart Washer presents at Proactive's CEO Sessions

The halt will remain in place until the opening of trade on Thursday 23rd November 2017, or earlier if an announcement is made to the market.

View full ZLD profile View Profile

Zelda Therapeutics Ltd Timeline

Related Articles

Skin beauty
April 19 2018
In a note to clients initiating coverage on SkinBio, the joint ‘house’ broker noted that, as the skin microbiome group operates in a new therapeutic area, there is little market data in the sector
cancer cell
February 01 2018
The highlights included successful US and European ovarian cancer studies that underlined the potential of the company’s Parsortix liquid biopsy system
Regeneus: Access latest PPT from Proactive's CEO Sessions
June 19 2017
John Martin discussed regenerative medicine with investors.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use